Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program, 2023
Discussion in 'Long Covid research' started by EndME, Oct 6, 2023.
Discussion in 'Long Covid research' started by EndME, Oct 6, 2023.